Welcome to LookChem.com Sign In|Join Free
  • or
1-(4-methoxyphenyl)-N-(1,1,1-trifluoropropan-2-ylidene)methanamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1334547-29-3

Post Buying Request

1334547-29-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1334547-29-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1334547-29-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,4,5,4 and 7 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1334547-29:
(9*1)+(8*3)+(7*3)+(6*4)+(5*5)+(4*4)+(3*7)+(2*2)+(1*9)=153
153 % 10 = 3
So 1334547-29-3 is a valid CAS Registry Number.

1334547-29-3Relevant academic research and scientific papers

Straightforward synthesis of 1-alkyl-2-(trifluoromethyl)aziridines starting from 1,1,1-trifluoroacetone

Kenis, Sara,D'Hooghe, Matthias,Verniest, Guido,Nguyen, Vinh Duc,Thi, Tuyet Anh Dang,Nguyen, Tuyen Van,Kimpe, Norbert De

, p. 7217 - 7223 (2011)

An efficient and straightforward approach towards the synthesis of 1-alkyl-2-(trifluoromethyl)aziridines starting from 1,1,1-trifluoroacetone via imination, α-chlorination, hydride reduction and ring closure was developed. In addition, novel primary β-iodo amines were obtained by regioselective ring opening of these 2-(trifluoromethyl)aziridines using alkyl iodides, and their synthetic potential was demonstrated by converting them into novel α-CF3-β-phenylethylamines upon treatment with lithium diphenylcuprate.

Pyridine and Pyrazine derivative for the Treatment of CF, COPD, and Bronchiectasis

-

Paragraph 0637, (2020/12/18)

The present invention provides pyridine and pyrazine derivatives which restore or enhance the function of mutant and/or wild type CFTR to treat bronchiectasis, cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory tract infections, lung carcinoma, xerostomia and keratoconjunctivitis sire, or constipation (IBS, IBD, opioid induced). Pharmaceutical compositions comprising such derivatives are also encompassed.

Pyridine and Pyrazine derivative for the Treatment of CF

-

Page/Page column 38-39, (2011/10/10)

The present invention provides pyridine and pyrazine derivatives which restore or enhance the function of mutant and/or wild type CFTR to treat cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory tract infections, lung carcinoma, xerostomia and keratoconjunctivitis sire, or constipation (IBS, IBD, opioid induced). Pharmaceutical compositions comprising such derivatives are also encompassed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1334547-29-3